Léon Muti

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Georges‐Philippe Pageaux, Clovis Lusivika‐Nzinga, Nathalie Ganne‐Carrié et al. · BMC Infectious Diseases · 2022 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Intraindividual variability over time of thrombin generation in patients with cirrhosis

Thomas Sinegre, Cédric Duron, Thomas Lecompte et al. · Journal of Thrombosis and Haemostasis · 2023 · 12 citations · Full text

Medicine, Internal Medicine, Pharmacokinetics +13

High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

Armand Abergel, C. Hézode, Tarik Asselah et al. · Journal of Hepatology · 2018 · 11 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13